Last reviewed · How we verify
mouse nerve growth factor
At a glance
| Generic name | mouse nerve growth factor |
|---|---|
| Also known as | mNGF |
| Sponsor | Zhujiang Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mature B-Cell Lymphoma And Leukemia Study III (PHASE2, PHASE3)
- Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial (PHASE4)
- Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease (PHASE4)
- Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence (NA)
- OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |